A Retrospective Analysis Of Efficacy Of Hemoadsorption (CYTOSORB�) In Refractory Septic Shock Patients As An Adjuvant
Article
| IMSEAR
| ID: sea-185592
ABSTRACT
Dysregulated response of cytokines can result in hyper-inflammatory conditions called cytokine storm,commonly seen in sepsis and septic shock..The current study assessed hemoadsorption device - CytoSorb® for its efficiency as an adjuvant in treating patients suffering from septic shock. Total 8 patients enrolled were subjected to hemoadsorption therapy along with the standard treatment.The results of the study revealed significant improvement in clinical and haemodynamic parameters before and after initiation of CytoSorb® therapy. Out of 8 patients, 6 showed a positive outcome while 2 did not survive.The results of this study show that the use of hemoadsorption therapy can be considered in critically ill ICU patients as a safe and effective adjuvant therapy along with the standard treatment for a better outcome in patients.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS